Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

A collaborative European research team led by physicists from Slovak Academy of Sciences has theorized a new approach to ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

How does F1 qualifying work? Here’s everything you need to know about the knockout format, pole position, new rules for 2022 and more. Formula 1 races may be on Sundays but all racing fans know that ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...

This study offers a valuable advance for neuroscience by extending a visualization tool that enables intuitive assessment of how dendritic and synaptic currents shape the output of neurons. The ...

Q3 2025 Management View Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." ...

Rigetti Computing, Inc. (NASDAQ:RGTI) is one of the stocks Jim Cramer recently answered questions about. When Cramer was asked about the company during the lightning round, he said: “You mean the one ...